128 related articles for article (PubMed ID: 11824579)
21. Synthesis and pharmacological effect of 6-halo-16 beta-methyl-pregnane derivatives.
Cabeza M; Gutiérrez E; Miranda R; Heuze I; Bratoeff E; Flores G; Ramírez E
Proc West Pharmacol Soc; 1998; 41():87-8. PubMed ID: 9836254
[No Abstract] [Full Text] [Related]
22. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
George FW
Endocrinology; 1997 Mar; 138(3):871-7. PubMed ID: 9048585
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of 3-tetrazolo steroidal analogs: Novel class of 5α-reductase inhibitors.
Aggarwal S; Mahapatra MK; Kumar R; Bhardwaj TR; Hartmann RW; Haupenthal J; Kumar M
Bioorg Med Chem; 2016 Feb; 24(4):779-88. PubMed ID: 26780831
[TBL] [Abstract][Full Text] [Related]
24. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line.
Amaral C; Varela C; Correia-da-Silva G; Tavares da Silva E; Carvalho RA; Costa SC; Cunha SC; Fernandes JO; Teixeira N; Roleira FM
Biochimie; 2013 Nov; 95(11):2097-106. PubMed ID: 23933094
[TBL] [Abstract][Full Text] [Related]
25. Steroids with a carbamate function at C-17, a novel class of inhibitors for human and hamster steroid 5alpha-reductase.
Bratoeff E; Sainz T; Cabeza M; Heuze I; Recillas S; Pérez V; Rodríguez C; Segura T; Gonzáles J; Ramírez E
J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):48-56. PubMed ID: 17629476
[TBL] [Abstract][Full Text] [Related]
26. Activity of 17beta-(N-alkyl/arylformamido) and 17beta-[(N-alkyl/aryl) alkyl/arylamido]-4-methyl-4-aza-5alpha-androstan-3-ones as 5alpha-reductase inhibitors in the hamster flank organ and ear.
Chen C; Li X; Singh SM; Labrie F
J Invest Dermatol; 1998 Aug; 111(2):273-8. PubMed ID: 9699729
[TBL] [Abstract][Full Text] [Related]
27. Novel 17 substituted pregnadiene derivatives as 5 alpha-reductase inhibitors and their binding affinity for the androgen receptor.
Cabeza M; Flores E; Heuze I; Sánchez M; Bratoeff E; Ramírez E; Francolugo VA
Chem Pharm Bull (Tokyo); 2004 May; 52(5):535-9. PubMed ID: 15133203
[TBL] [Abstract][Full Text] [Related]
28. Steroidal antiandrogens and 5alpha-reductase inhibitors.
Bratoeff E; Ramírez E; Murillo E; Flores G; Cabeza M
Curr Med Chem; 1999 Dec; 6(12):1107-23. PubMed ID: 10519917
[TBL] [Abstract][Full Text] [Related]
29. Molecular interactions of progesterone derivatives with 5 alpha-reductase types 1 and 2 and androgen receptors.
Bratoeff E; García P; Heuze Y; Soriano J; Mejía A; Labastida AM; Valencia N; Cabeza M
Steroids; 2010 Jul; 75(7):499-505. PubMed ID: 20359488
[TBL] [Abstract][Full Text] [Related]
30. Antiandrogen. III. 11-oxapregnane steroids.
Takegawa S; Koizumi N; Mieda M; Shibata K
Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):746-8. PubMed ID: 8681406
[TBL] [Abstract][Full Text] [Related]
31. Testosterone regulates levels of cystic fibrosis transmembrane regulator, adenylate cyclase, and cAMP in the seminal vesicles of orchidectomized rats.
Ramli NS; Giribabu N; Muniandy S; Salleh N
Theriogenology; 2016 Jan; 85(2):238-46. PubMed ID: 26483308
[TBL] [Abstract][Full Text] [Related]
32. Antiandrogenic activity of a series of des-A-steroid derivatives.
Morales-Alanis H; Brienne MJ; Jacques J; Bouton MM; Nédélec L; Torelli V; Tournemine C
J Med Chem; 1985 Dec; 28(12):1796-803. PubMed ID: 4068004
[TBL] [Abstract][Full Text] [Related]
33. Effects of topically applied antiandrogenic compounds on sebaceous glands of hamster ears and flank organs.
Schröder HG; Ziegler M; Nickisch K; Kaufmann J; el Etreby MF
J Invest Dermatol; 1989 May; 92(5):769-73. PubMed ID: 2715647
[TBL] [Abstract][Full Text] [Related]
34. Antiandrogenic activity of epitestosterone in male mice in vivo.
Stárka L; Broulík PD
Sb Lek; 2001; 102(1):7-11. PubMed ID: 11830921
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological activity of progesterone derivatives as 5alpha-reductase inhibitors, and their effect on hamster prostate weight.
Bratoeff E; Zambrano A; Heuze I; Palacios A; Ramírez D; Cabeza M
J Enzyme Inhib Med Chem; 2010 Jun; 25(3):306-11. PubMed ID: 19874206
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
Imperato-McGinley J; Sanchez RS; Spencer JR; Yee B; Vaughan ED
Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152
[TBL] [Abstract][Full Text] [Related]
37. Growth suppression of hamster flank organs by topical application of gamma-linolenic and other fatty acid inhibitors of 5alpha-reductase.
Liang T; Liao S
J Invest Dermatol; 1997 Aug; 109(2):152-7. PubMed ID: 9242500
[TBL] [Abstract][Full Text] [Related]
38. Local and systemic reduction by topical finasteride or flutamide of hamster flank organ size and enzyme activity.
Chen C; Puy LA; Simard J; Li X; Singh SM; Labrie F
J Invest Dermatol; 1995 Nov; 105(5):678-82. PubMed ID: 7594643
[TBL] [Abstract][Full Text] [Related]
39. Relative binding affinity of novel steroids to androgen receptors in hamster prostate.
Cabeza M; Heuze I; Sánchez M; Bratoeff E; Ramírez E; Rojas A; Orozco A; Mungía A; Agustín G; Cuatepotzo L; Gonzalez C; Palma S; Padilla D; Perez V; Jimenez G
J Enzyme Inhib Med Chem; 2005 Aug; 20(4):357-64. PubMed ID: 16206830
[TBL] [Abstract][Full Text] [Related]
40. Prolactin influences upon androgen action in male accessory sex organs.
Thomas JA; Keenan EJ
Adv Sex Horm Res; 1976; 2():425-70. PubMed ID: 189591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
